Tag: VNS

vivistim system

MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...

MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...

New study shows significant positive impact of vagus nerve stimulation therapy...

Adding vagus nerve stimulation (VNS) therapy to treatment as usual has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD). In...
LivaNova RECOVER design published

RECOVER trial design evaluating vagus nerve stimulation for treatment-resistant depression published

LivaNova announces a publication in Contemporary Clinical Trials, which details the design for a prospective, multicentre, randomised controlled blinded trial demonstrating the safety and...
Peter Staats COVID-19 nVNS

Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...

An article accepted into the journal Neuromodulation has concluded that, based on two case reports, non-invasive vagus nerve stimulation (nVNS) might provide clinical benefits...

LivaNova’s VNS Therapy receives CE mark for expanded MRI labelling

LivaNova's latest VNS Therapy system has received CE mark for expanded MRI labelling. VNS Therapy is now the only implantable device indicated for epilepsy...